Google
Trusted Resources: News & Events
Latest announcements and gatherings
Lab-Grown Blood: What Is It, and How Could It Be Useful?
Sometimes a person may have a blood disorder causing their blood to not act as it should. One of these disorders is sickle cell disease, which affects the body’s red blood cells. Sickle cell disease is the most common genetic disease in the United States, with a high prevalence in people of African descent.
There are different types of blood and some are rarer than others. People can have rare blood types that make transfusion difficult if they are in an accident or need surgery. For example, AB negative is the rarest blood type with only 1% of the general population having it.
To help combat these issues, a team of researchers led by the United Kingdom’s National Health Service (NHS) Blood and Transplant (NHSBT) unit recently launched the first clinical trial to ever transfuse laboratory-grown red blood cells into a live human.
+myBinderRelated Content
-
From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell diseaseErythrocytapheresis is an important proc...
-
Incidence and Risk of Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients Based on a Prospective ...Background: Delayed hemolytic transfusi...
-
La Jolla Pharmaceutical company announces initiation of pivotal clinical study of LJPC-401 in patients with beta tha...La Jolla Pharmaceutical company today an...
-
Miai & Ama Talk About Sickle Cell Diseasehttps://www.youtube.com/watch?v=7bUFGux-...
-
Spectra Optia Device Save Way to Treat Sickle Cell While Using Less Blood Cell Packs, Study FindsThe blood-separation device Spectra Opti...
-
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic PartnershipSickle Cell Disease Association of Ameri...
-
Sickle Cell Treatment ‘Life-Changing’ for Brockton BrothersEmmanuel “Manny” Johnson, 21, of Bro...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.